• News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • Investors
    • Overview
    • Rights Issue 2026
      • Rights Issue 2026
      • Prospectus and legal information
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Rights Issue 2026
    • Rights Issue 2026
    • Prospectus and legal information
  • Contact
    • Contact
    • Career
logo
  • News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • Investors
    • Overview
    • Rights Issue 2026
      • Rights Issue 2026
      • Prospectus and legal information
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Rights Issue 2026
    • Rights Issue 2026
    • Prospectus and legal information
  • Contact
    • Contact
    • Career
Home / Investors / The Share / Largest Shareholders
  • Overview
  • Rights Issue 2026
    • Rights Issue 2026
    • Prospectus and legal information
  • Analyses
  • Press Releases
    • English
    • Swedish
    • Subscribe
  • Presentations
  • Board and Management
  • The Share
  • Financial Reports
    • Financial Reports - English
    • Financial Reports – Swedish
    • Financial Calendar
  • Corporate Governance
  • General Meetings
  • IR Contact

Largest Shareholders

As per Euroclear, 30 September 2025

Name

Capital %

Votes %

No. of shares

Maida Vale Capital AB 16.83 16.83 17,558,901
Försäkrings AB Avanza Pension 7.41 7.41 7,735,234
Nordnet Pensionsförsäkring AB 3.75 3.75 3,912,152
Patrik Ahlvin 3.07 3.07 3,200,000
Ålandsbanken, for owner 1.63 1.63 1,696,541
Özlem Erdogdu Gül 1.57 1.57 1,635,000
Sara Gjertz 1.34 1.34 1,400,684
Marcus Milerud 1.18 1.18 1,232,098
Mollbro AB 1.01 1.01 1,051,990
Reijo Antti Tapani Nurkkala 0.86 0.86 896,146
Total 10 largest owners 38.65 38.65 40,318,746
Total other owners 61.35 61.35 64,004,842
Total all owners 100.00 100.00 104,323,588

 

 

 

 

  • News
  • Our Company
  • Patients & Families
  • R & D
  • Investors
  • Contact

Alzinova AB, Gemenskapens gata 9,  SE-431 53 Mölndal
info@alzinova.com

Follow us on

follow us on linkedin